Northern Trust Corp Scynexis Inc Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Scynexis Inc stock. As of the latest transaction made, Northern Trust Corp holds 82,684 shares of SCYX stock, worth $68,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,684

Previous 137,614 39.92%

Holding current value

$68,627

Previous $130,000 57.69%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.67 - $1.07 $36,803 - $58,775	-54,930 Reduced 39.92%	82,684 $55,000
Q1 2025 May 13, 2025	SELL	$0.9 - $1.41 $14,313 - $22,424	-15,904 Reduced 10.36%	137,614 $130,000
Q4 2024 Feb 14, 2025	BUY	$1.0 - $1.53 $52,466 - $80,272	52,466 Added 51.92%	153,518 $176,000
Q3 2024 Nov 13, 2024	SELL	$1.27 - $2.23 $1,356 - $2,381	-1,068 Reduced 1.05%	101,052 $150,000
Q2 2024 Aug 14, 2024	SELL	$1.4 - $2.77 $3,178 - $6,287	-2,270 Reduced 2.17%	102,120 $204,000
Q1 2024 May 14, 2024	SELL	$1.39 - $2.21 $9,090 - $14,453	-6,540 Reduced 5.9%	104,390 $153,000
Q4 2023 Feb 13, 2024	BUY	$1.56 - $2.24 $91,603 - $131,532	58,720 Added 112.47%	110,930 $247,000
Q3 2023 Nov 13, 2023	SELL	$1.93 - $3.64 $4,267 - $8,048	-2,211 Reduced 4.06%	52,210 $119,000
Q2 2023 Aug 11, 2023	BUY	$2.38 - $3.67 $14,582 - $22,486	6,127 Added 12.69%	54,421 $160,000
Q1 2023 May 15, 2023	BUY	$1.15 - $3.0 $7,067 - $18,438	6,146 Added 14.58%	48,294 $144,000
Q3 2022 Nov 14, 2022	BUY	$1.83 - $2.93 $9,669 - $15,482	5,284 Added 14.33%	42,148 $101,000
Q2 2022 Aug 12, 2022	BUY	$1.77 - $3.87 $2,998 - $6,555	1,694 Added 4.82%	36,864 $69,000
Q1 2022 May 13, 2022	SELL	$3.56 - $6.66 $16,489 - $30,849	-4,632 Reduced 11.64%	35,170 $138,000
Q4 2021 Feb 08, 2022	BUY	$4.94 - $7.69 $12,809 - $19,940	2,593 Added 6.97%	39,802 $242,000
Q3 2021 Nov 15, 2021	BUY	$5.3 - $7.89 $14,845 - $22,099	2,801 Added 8.14%	37,209 $197,000
Q1 2021 May 12, 2021	BUY	$6.93 - $9.63 $102,369 - $142,254	14,772 Added 75.23%	34,408 $273,000
Q4 2020 Feb 11, 2021	BUY	$4.28 - $7.87 $9,022 - $16,589	2,108 Added 12.03%	19,636 $150,000
Q3 2020 Nov 16, 2020	BUY	$4.37 - $7.48 $76,597 - $131,109	17,528 New	17,528 $77,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

11.8M

Call Options Held

Put Options Held

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $27.1M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Scynexis Inc Transaction History